Found 0 matching trials
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
PHASE3X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-contro...
Location
IMA Clinical Research Phoenix
Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN1101
PHASE1The XEN1101 Phase 1 clinical trial is a randomized, double-blind, placebo-c...
Location
King's College Hospital
Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.
PHASE1The XEN1101 Phase 1 clinical trial is a randomized, double-blind, placebo-c...
Location
Richmond Pharmacology Ltd.
An Open-Label Study of Azetukalner in Major Depressive Disorder
PHASE3X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term saf...
Status
Enrolling By Invitation
Location
Ima Clinical Research - Phoenix
XEN1101 for Major Depressive Disorder
PHASE2This project is designed to examine the neuronal KCNQ2/3 potassium (K+) cha...
Location
Icahn School of Medicine at Mount Sinai